Redwire Launching Upgraded 3D Bioprinter to Space Station to Investigate New Treatment to Aid Military Service Members, Expands Crop Production Research and Materials Testing on Orbit
02 11월 2022 - 8:00PM
Business Wire
Redwire Corporation (NYSE: RDW), a leader in space
infrastructure for the next generation space economy, is launching
its upgraded 3D bioprinter, the BioFabrication Facility (BFF),
along with three other payloads on Northrop Grumman’s 18th cargo
resupply services mission (NG-18) for NASA to the International
Space Station (ISS). The mission is scheduled to lift off no
earlier than Sunday, November 6 at 5:50 a.m. EST from the
Mid-Atlantic Regional Spaceport Pad 0A on Wallops Island,
Virginia.
BFF is an exciting capability that 3D prints human cells in
space to fabricate complex tissue structures and eventually organs
that could one day be used to help patients on Earth. Redwire is
working with the Uniformed Services University of the Health
Sciences Center for Biotechnology (4DBio3), a biomedical research
center that explores and adapts promising biotechnologies for
warfighter benefit, to explore how space bioprinting could help
treat meniscal injuries, one of the most common orthopedic injuries
affecting U.S. military service members. The BFF-Meniscus-2
investigation will leverage BFF and Redwire’s ADvanced Space
Experiment Processor (ADSEP) facility, both launching onboard
NG-18, to bioprint a human knee meniscus in space that will be
studied in a lab following the sample’s return to Earth.
“BFF is game-changing technology that could have significant
implications for the future of human health and patient care on
Earth,” said Redwire Executive Vice President of In-Space
Manufacturing and Operations John Vellinger. “The ISS provides a
critical testing platform to advance these cutting-edge
technologies that are enabling critical investigations from
commercial users and the scientific research community that will
one day extend to future commercial space stations.”
3D bioprinting entire organs in space to benefit patients on
Earth is a long-term goal for BFF. In the near-term, BFF is also a
valuable tool for drug efficacy testing. BFF can print and culture
organoids, an artificially grown mass of cells or tissue that
resembles an organ. Researchers can test new drug compounds on
these organoids and derive meaningful data which can greatly
benefit drug development research, disease modeling research and
tissue engineering approaches.
Redwire is also launching a plant science investigation, The
Epigenetic Adaptation to the Spaceflight Environment - Accumulated
Genomic Change Induced by Generations in Space (Plant Habitat-03)
investigation, that could help identify the genetic elements that
increase the adaptability of plants to spaceflight. The Plant
Habitat-03 investigation, which will be conducted using NASA’s
Advanced Plant Habitat—an automated plant growth facility managed
by Redwire, builds upon Redwire's three previous successful
investigations that grew radishes, chili peppers, and cotton tissue
culture in space. This investigation could help develop strategies
for adapting crops and other economically important plants for
growth in marginal and reclaimed habitats on Earth.
Also launching on this mission is the Asymmetric Sawtooth and
Cavity-Enhanced Nucleation-Driven Transport investigation, or
PFMI-ASCENT. The investigation seeks to demonstrate a passive
cooling system for electronic devices in microgravity using a
microstructured surface. The investigation will use NASA’s
space-based research furnace, the Pore Formation and Mobility
Investigation (PFMI) facility, which is managed by Redwire. The
long-term goal of this research is to develop a simple, passive,
self-regulating microstructured surface technology for heat sinks
used in consumer electronics and avionics. The investigation is a
collaboration between researchers at Auburn University and
University of California-Davis.
Redwire has a large and diverse catalog of equipment and
services for conducting research in microgravity for federal,
institutional and industrial customers. The Redwire technology
launching on this mission includes experiments focused on advancing
biomedical capabilities, advanced materials manufacturing, and
plant biology, demonstrating the breadth of Redwire’s on-orbit
capabilities to accelerate more scientific discovery and deliver
more beneficial products to Earth.
To learn more about the science and technology that Redwire is
launching on Northrop Grumman’s NG-18 cargo resupply mission,
visit: www.redwirespace.com.
About Redwire
Redwire Corporation (NYSE: RDW) is a leader in space
infrastructure for the next generation space economy, with valuable
IP for solar power generation and in-space 3D printing and
manufacturing. With decades of flight heritage combined with the
agile and innovative culture of a commercial space platform,
Redwire is uniquely positioned to assist its customers in solving
the complex challenges of future space missions. For more
information, please visit www.redwirespace.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221102005362/en/
Media Contact: Tere Riley Tere.Riley@redwirespace.com
321-831-0134
OR
Investors: investorrelations@redwirespace.com
904-425-1431
Redwire (NYSE:RDW)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Redwire (NYSE:RDW)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024